NEWS

19 September 2023

BMS’ Successful Securing of General Research Fund (GRF) 2023/2024

/
/
BMS’ Successful Securing of General Research Fund (GRF) 2023/2024.
BMS’ Successful Securing of General Research Fund (GRF) 2023/2024.

CityU Department of Biomedical Sciences (BMS) is pleased to announce the results of the Research Grants Council’s General Research Fund (GRF) for 2023–2024. BMS has once again demonstrated its excellence in research by obtaining nine GRF grants totaling over HK$12M.

The GRF aims to supplement the eight UGC-funded universities’ own research support to researchers who have achieved or have the potential to achieve research excellence. Among the awarded projects in BMS, seven of them have obtained large grants of over $1.4M.

The outstanding results are a testament to our faculty’s hard work and dedication. The Department would like to extend its heartfelt congratulations to the following colleagues and express its gratitude to all faculty staff for their contributions to submitting high-standard proposals in this round.

Principal Investigator (PI) Project Title
CHAN Kui Ming Investigate the mechanism of H2BG53D mutation in pancreatic ductal adenocarcinoma
CHOW Kwan Ting Understanding the myeloid-specific IRF5-mediated immune response in breast cancer
DENG Xin Probing a novel negative regulatory cascade in Pseudomonas syringae virulence
HUANG Yu Critical roles of endothelial FOXO-1 activation in endothelial dysfunction during hypertension development
LO P. C. Gigi Targeted Protein Degradation by Photosensitization Triggering Ferroptosis for Enhanced Antitumor Immunity
WANG Li TNFAIP2 secreted by endothelial cells promotes atherosclerosis by inducing macrophage migration
XIONG Wenjun Elucidating the function of DKK1 and IGF1 in mouse eye size regulation through activating the AKT signaling in the retinal pigment epithelium
YUAN H. Y. Sean Identifying vaccine target groups to reduce COVID-19 hospitalisations by modelling waning immunity
ZHENG Zongli Circulating biomarkers and hepatocellular carcinoma in a high-risk population
More News